Integrated phenotypic screening and activity-based protein profiling to reveal potential therapy targets of

Wenyan Liu1, Zhang Zhang, Zhi-Min Zhang

  • 1School of Pharmacy, Jinan University; Guangzhou City Key Laboratory of Precision Chemical Drug Development; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MOE) of People's Republic of China, 601 Huangpu Avenue West, Guangzhou, 510632, China. pharmlzq@jnu.edu.cn.

Chemical Communications (Cambridge, England)
|January 19, 2019
PubMed

Insights

Researchers identified novel therapeutic targets for pancreatic cancer by screening a compound library. Two potent inhibitors, P21 and P26, were discovered, with GSTO1 validated as a key target to impair cancer cell survival.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Proteomics

Background:

  • Pancreatic cancer presents significant treatment challenges with limited validated therapeutic targets.
  • Identifying novel strategies to combat this complex disease is crucial.

Purpose of the Study:

  • To discover and validate new therapeutic targets for pancreatic cancer.
  • To identify potent small molecules that inhibit pancreatic cancer cell survival.

Main Methods:

  • A 61-compound library was synthesized using the Ugi reaction.
  • Phenotypic screening was employed to identify active compounds.
  • Quantitative chemoproteomics was used to identify protein targets.
  • GSTO1 was validated as a key cellular target.

Main Results:

  • Two potent inhibitors, P21 and P26, were discovered, significantly reducing BxPC-3 pancreatic cancer cell survival.
  • Proteins including GSTO1, FAM213A, RAB6A/6B/39A, and USMG5 were identified as interacting partners.
  • GSTO1 was confirmed as the primary cellular target.

Conclusions:

  • GSTO1 represents a novel and validated therapeutic target for pancreatic cancer.
  • The identified inhibitors demonstrate potential for further drug development against pancreatic cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Thermodynamics: Chemical Potential and Activity01:10

Thermodynamics: Chemical Potential and Activity

The effective concentration of a species in a solution can be expressed precisely in terms of its activity. Activity considers the effect of electrolytes present in the vicinity of the species of interest and depends on the ionic strength of the solution. The activity of a species is expressed as the product of molar concentration and the activity coefficient of the species.
The thermodynamic equilibrium constant is more accurately defined in terms of activity rather than concentration.
1.7K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.4K
Acid–Base Equilibria: Activity-Based Definition of pH01:10

Acid–Base Equilibria: Activity-Based Definition of pH

For an ideal solution, the pH is defined as the negative logarithm of the hydrogen ion concentration. For a non-ideal solution, an accurate measurement of the pH must consider the negative logarithm of the hydrogen ion activity rather than concentration. In such a solution, the pH can be more accurately defined as the negative logarithm of a product of the hydrogen ion concentration and its activity coefficient.
In solutions of very low ionic strength—for example, pure water—the...
1.3K